News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1โ€“36
Matches
58
Sources here
18
Companies here
1
Search results Stored financial headlines

Active search

58 matching headlines

Main companies and provider mentions
Clear
Latest

Barron's Analyst action

Cerus Corp. Stock Grades | CERS

This article provides a stock grade overview for Cerus Corp. (CERS), including its average analyst price target and score, sentiment, and key financial metrics like market value, EPS, and short interest. It also details the company's business activities in biomedical and surgical product development, specifically its INTERCEPT brand for blood systems.

CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas

The article provides the latest stock price for Cerus Corp. (CERS), showing it closed at $2.34 with a slight after-hours gain. It includes investor sentiment and trading ideas, with one investor anticipating a significant share price increase based on upcoming data related to RBC. โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

Cerus (NASDAQ:CERS) stock recently crossed above its 200-day moving average, trading at $2.53 with a 200-day moving average of $2.48. Analyst sentiment is mixed, with a consensus "Hold" rating and an average price target of $5.25. The company met its quarterly EPS expectations and โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus (NASDAQ:CERS) Upgraded at Wall Street Zen

Wall Street Zen has upgraded Cerus (NASDAQ:CERS) from a "hold" to a "buy" rating, despite the broader analyst consensus remaining "Hold" with an average price target of $5.25. Cerus met analyst expectations with quarterly revenue of $63.3 million and an adjusted EPS of $(0.01), โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale

Chrystal Nikole Jensen, an insider at Cerus (NASDAQ: CERS), has filed a Form 144 notice to sell up to 30,000 shares of common stock through Morgan Stanley Smith Barney LLC on August 17, 2026. This proposed sale follows a previous sale of 24,329 common โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp chief legal officer sells $89,529 in company stock.

Chrystal Jensen, Chief Legal Officer at Cerus Corp (NASDAQ:CERS), sold 30,000 shares of company stock totaling $89,529 on August 17, 2026, as part of a pre-arranged trading plan. The sale occurred while Cerus shares were trading near $2.97, reflecting significant gains over the past โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus (CERS) legal chief sells 30,000 shares in preset plan

Cerus (CERS) Chief Legal Officer Chrystal Jensen sold 30,000 shares of common stock on August 17, 2026, as part of a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $2.9843, with individual prices ranging from $2.92 to $3.04. โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Baker Bros. cuts Cerus Corporation (CERS) position to 3.2% ownership stake

Baker Bros. Advisors LP and related reporting persons have filed an Amendment No. 13 indicating a reduction in their beneficial ownership of Cerus Corporation (CERS) common stock to 3.2%. This ownership comprises 6,395,431 shares held by Baker Brothers Life Sciences, L.P. and 667, L.P., โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp (CERS): ARK Investment, Catherine Wood report 8.95% ownership stake

ARK Investment Management LLC and its CEO/CIO Catherine D. Wood have reported a beneficial ownership stake of 8.95% in Cerus Corp (CERS) common stock through an amended Schedule 13G/A filing. As of June 30, 2026, they collectively own 17,932,099 shares. The filing details ARK's โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp (CERS) sees Soleus Capital group report 1.2% beneficial stake

Soleus Capital Master Fund, L.P., and its related entities, including Guy Levy, have filed an amended Schedule 13G indicating beneficial ownership of 2,500,000 shares of Cerus Corporation (CERS) common stock, which represents 1.2% of the outstanding shares. This filing confirms that the group now โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Wasatch Advisors LP Sells 1,897,237 Shares of Cerus Corporation $CERS

Wasatch Advisors LP reduced its stake in Cerus Corporation by 35.9% in the second quarter, selling 1,897,237 shares but still retaining 3.38 million shares valued at approximately $9.9 million. Cerus reported quarterly revenue of $63.3 million and an adjusted loss of $0.01 per share, โ€ฆ

CERS mentioned
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp (CERS) Stock News Today

This page provides the latest news and information for Cerus Corp (CERS) stock on TradingKey, a financial information platform. As of August 7th, Cerus Corp's stock closed at $2.350, up 1.29%. The platform also offers an overview, news and analysis, financial data, stock score, โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of $5.00, suggesting a 113.09% upside. Based on 3 analysts, the stock is rated as a "Buy." The company's expected revenue for the โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus Corp 2Q 2026: Revenue $57.4M, EPS $(0.01) โ€” 10-Q Summary

Cerus Corp (CERS) reported its second-quarter 2026 results, showing revenue of $57.4 million, an increase from $52.4 million in the prior year. The company also narrowed its net loss to $(2.94) million from $(5.71) million, and its diluted loss per share improved to $(0.01) โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

CERS Slides After Sharp Repricing Raises Trading Focus

Cerus Corporation (CERS) stock has dropped significantly by 23.88% due to adverse regulatory news and increased bearish sentiment. The company, which operates in blood safety, shows solid revenue growth but remains unprofitable, making it a high-risk, high-reward stock for traders. Analysts note its adequate โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Friday's ETF Movers: GXUS, ARKK

In trading on Friday, the Goldman Sachs MarketBeta Total International Equity ETF is outperforming other ETFs, up about 2.9% on the day. Components of that ETF showing particular strength include shares of Vista Energy, up about 1.2% and shares of Grab Holdings, up about โ€ฆ

CERS mentioned
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus outlines $229M-$231M 2026 product revenue outlook as IFC guidance rises to $23M-$25M

Earnings Call Insights: Cerus Corporation (CERS) Q2 2026 MANAGEMENT VIEW * CEO, President & Director Vivek Jayaraman said Q2 progress was anchored on โ€œ3 core priorities: delivering sustainable double-digit growth, advancing innovation, and strengthening our financial foundation,โ€ and reported that โ€œworldwide product revenue increased โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus (NASDAQ:CERS) Announces Earnings Results, Meets Expectations

Cerus (NASDAQ:CERS) announced its earnings results, meeting analyst expectations with a quarterly loss of $0.01 per share and revenue of $63.3 million, slightly above the $62.9 million forecast. The company reported a 10% increase in product revenue to $57.4 million, driven by significant growth โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Earnings call transcript: Cerus beats Q2 2026 estimates but shares fall after hours

Cerus Corporation reported Q2 2026 results that surpassed analyst estimates for both profit and revenue, with an adjusted EPS loss of $0.01 against an expected loss of $0.03, and revenue of $63.3 million compared to a $62.9 million forecast. Despite the beat and raised โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Cerus reports Q2 2026 revenue $63.3M; product revenue $57.4M, raises 2026 product guidance

Cerus reported Q2 2026 total revenue of $63.3 million and product revenue of $57.4 million, marking a 10% year-over-year increase. The company raised its full-year product revenue guidance to $229โ€“$231 million and highlighted accelerating demand for INTERCEPT Fibrinogen Complex in the U.S. Cerus also โ€ฆ

CERS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.3% CERS stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context